Atlas Trials

Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients

Clinical trial NCT02815410 · UNKNOWN

Trial details

NCT number
NCT02815410
Sponsor
Seoul National University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma Multiforme
Start date
2016-07-01
Primary completion
2019-06-01
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.